More Evidence for Oxaliplatin as Colon Cancer Chemotherapy, University of Virginia Study

Adding oxaliplatin to a standard chemotherapy regimen boosts survival rates for patients with advanced colon cancer, according to a new study that bolsters previous research on the drug by looking at a broader group of patients.

Back to news